World Journal of Otorhinolaryngology – Head and Neck Surgery
Click on the title to browse this journal
Related Articles
The top 10 gadgets of 2024
As part of our review of 2024, we’ve collated this year’s best gadgets including a transparent laptop, a medieval beat machine and powered hiking trousers.
PRICE-2: Hypovolaemic Phlebotomy Reduces Blood Transfusions After Liver Resection
Hypovolaemic phlebotomy reduced perioperative blood transfusion and improved operative conditions versus usual care in patients undergoing liver resection.
Allogeneic Stem Cell Donation
Allogeneic stem cell transplantation is a potentially life-saving therapy for some patients with hematologic and bone marrow cancers and certain nonmalignant conditions such as sickle…
Participant Support for Changes to the Supplemental Nutrition Assistance Program
This cross-sectional study reports participant attitudes regarding 11 Supplemental Nutrition Assistance Program policies and stratified by self-reported political affiliation.
Lonza to exit capsules and health ingredients business, focus on contract development
Swiss contract drugmaker Lonza plans to exit its capsules and health ingredients (CHI) business, it said on Thursday, after demand for pharmaceutical supplies declined following…
Will Open AI’s o1 Reasoning Model Really Change The World?
OpenAI’s o1 models, launched in September 2024, introduce a new paradigm in AI reasoning called chain-of-thought reasoning.
What I’ve learned — the hard way — about AI in bio
Presenting the five stages of AI grief (techbio’s version), from Tessel Bio’s @NTallapragada.
Samsung’s next rugged phone has a bigger user-removable battery
While excitement around One UI 7.0 and the Galaxy S25 series keeps building up, we just got a reminder that …
Durvalumab and tremelimumab in patients with advanced rare cancer: a multi-centre, non-blinded, open-label phase II basket trial
Durvalumab + tremelimumab treatment resulted in meaningful responses in salivary carcinoma and CCCO and deserves further exploration in front-line studies.
Labcorp completes acquisition of Ballad Health lab assets
Ballad Health will retain operations of its inpatient and emergency department laboratory services.
